MedTrace Logo

ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD

NCT02753556 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2018-02-01

No results posted yet for this study

Summary

ScreenFlow is a chronic obstructive pulmonary disease (COPD) screening tool currently being studied and iteratively developed that incorporates a questionnaire administered on a tablet and data from a digital peak flow meter to calculate a risk score to identify the risk of developing moderate-to-severe COPD for the participant. The purpose of this study is to assess the usability of ScreenFlow deployed as a free-standing kiosk and observe where users encounter trouble navigating the system. The kiosk will be situated in a public area of a hospital where passersby can approach and fill out a ScreenFlow survey if they meet the eligibility criteria. A subset of participants will be asked to participate in a follow-up questionnaire about their experience using the system and about any follow-up action they may have taken caused by their results from the ScreenFlow screening.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • Boston Medical Center

    collaborator OTHER

  • Dimagi Inc.

    lead INDUSTRY

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02753556 on ClinicalTrials.gov